Summary:
Are you or a loved one living with Alzheimer’s disease? Are you looking for potential treatment options?
Common symptoms of Early Alzheimer’s disease include memory loss, challenges in planning or solving problems, difficulty completing tasks, confusion with time or place, misplacing things, withdrawal from social activities, and changes in mood.
If you or a loved one have memory or thinking issues or have been diagnosed with early Alzheimer's disease you may qualify for a clinical research study. EIP Pharma is seeking volunteers for a clinical study assessing the safety and effectiveness of an investigational medication in potentially slowing the progression of early Alzheimer’s disease.
Participants may qualify if they:
- Are between the ages of 55 and 85
- Are experiencing issues with memory, confusion, or thinking clearly
- Have a study partner willing to attend certain study visits throughout the duration of the study
All study-related medications and assessments will be provided at no-cost.